Correlation of Ureum and Creatinine Levels in Tuberculosis Patients at Ciawi Public Health Center, Bogor District
Main Article Content
Abstract
Tuberculosis is a disease caused by the bacterium Mycobacterium tuberculosis. Tuberculosis patients are required to undergo anti-tuberculosis drug therapy in the long term which can result in accumulation of metabolic waste in the body, decreased excretion which is characterized by an increase in urea and creatinine levels. The purpose of this study was to analyze the relationship between urea and creatinine levels in tuberculosis patients at the Ciawi Health Center, Bogor Regency. The design used is descriptive analysis with a cross sectional approach. Examination of urea and creatinine levels using serum with an Erba Chem 5 V3 spectrophotometer. The data analysis used was the chi square test. The results showed that there was a relationship between urea and creatinine levels in tuberculosis patients at the Ciawi Health Center, Bogor Regency, based on gender with ap value of urea 0.011 and creatinine 0.005 (α<0.05), based on age with ap value of urea 0.004 and creatinine 0.030 (α <0.05) and there was no relationship based on length of treatment with p values 0.626 and 0.860 (α > 0.05).
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Adigun, Rotimi, and Rahulkumar Singh. 2020. Tuberculosis. Statpearls Publishing.
II. Efendi, V. 2019. Description of Urea and Creatinine Levels in Pulmonary Tuberculosis Patients after Consuming Anti-Tuberculosis Drugs (OAT) at Dr. Chasbullah Abdulmadjid Regional Hospital. Bekasi. Scientific Paper. POLTEKKES III, Jakarta.
III. Harison, MF 2019. Description of Urea and Creatinine Levels in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Drug (OAT) Therapy at the Special Lung Hospital of South Sumatra Province in 2019. Palembang: Palembang Health Polytechnic.
IV. Hoagland et al. 2016. New Agents for the Treatment of Drug Resistant Mybacterium Tuberculosis (pp. 55-72).
V. InfoDatin Data and Information Center of the Ministry of Health of the Republic of Indonesia. 2018. Tuberculosis. Retrieved November 03, 2021, from File://C:/Users/Download/Infodatin%20tub erkulosis%2018. pdf
VI. Ministry of Health, Republic of Indonesia. 2019. National Guidelines for Tuberculosis Management Medical Services. Jakarta. https://yankes.kemkes.go.id.Accessed November 24, 2021.
VII. Minists.kemkes.go.id.Accessed November 24, 2021.
ry of Health of the Republic of Indonesia. 2018. InfoDatin Tuberculosis. Ministry of Health. https://d3v.kemkes.go.id. Accessed June 04, 2022
VIII. Kustiana, U. 2018. Description of Creatinine Levels in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Drug (OAT) Therapy at the Special Lung Hospital of South Sumatra Province in 2018. Scientific Paper. POLTEKKES Palembang.
IX. Mansur, Ruminis. 2020. Urea Description of Pulmonary Tuberculosis Patients Consuming Anti-Tuberculosis Drugs for Six Months at Advent Medan Hospital. Scientific Paper. POLTEKKES RI Medan.
X. Simanjuntak, FM 2015. Examination of Urea Levels in Diabetes Mellitus Patients Aged 55-65 Years at Sari Mutiara General Hospital, Medan in 2015. Medicine and Health: Medan..
XI. Triputri, N. 2015. Analysis of Urea Levels in Serum of Pulmonary TB Patients Consuming Anti-Tuberculosis Drugs for More Than 4 Months. Medan: Sari Mutiara Sari University
XII. Verdiansah. 2016. Kidney Function Examination. Bandung, Indonesia.
XIII. WHO. 2018. Global Tuberculosis. https://apps.who.int. Accessed 18 August 2021.
XIV. WHO. 2019. Tuberculosis Profile: Indonesia. https://www.who.int.Accessed October 20, 2021.